[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.4014/jmb.1405.05073

Construction of Chimeric Human Epidermal Growth Factor Containing Short Collagen-Binding Domain Moieties for Use as a Wound Tissue Healing Agent

Kim, Dong-Gyun (Biotechnology Research Division, National Fisheries Research and Development Institute)
Kim, Eun-Young (Institute of Fisheries Science, Pukyong National University)
Kim, Yu-Ri (CBR Defense Research Institute, The Armed Forces CBD Defense Command)
Kong, In-Soo (Department of Biotechnology, Pukyong National University)

Publication Information

Journal of Microbiology and Biotechnology / v.25, no.1, 2015 , pp. 119-126 More about this Journal

Abstract

Among the various human growth factors, epidermal growth factor (hEGF, consisting of 53 amino acids) has various effects on cell regeneration, stimulation of proliferation, migration of keratinocytes, formation of granulation tissues, and stimulation of fibroblast motility, which are important for wound healing. Owing to their multiple activities, EGFs are used as pharmaceutical and cosmetic agents. However, their low productivity, limited target specificity, and short half-life inhibit their application as therapeutic agents. To overcome these obstacles, we fused the collagen-binding domain (CBD) of Vibrio mimicus metalloprotease to EGF protein. About 18 or 12 amino acids (aa) (of the 33 total amino acids), which were essential for collagen-binding activity, were combined with the N- and C-termini of EGF. We constructed, expressed, and purified EGF (53 aa)-CBD (18 aa), EGF (53 aa)-CBD (12 aa), CBD (18 aa)-EGF (53 aa), and CBD (12 aa)-EGF (53 aa). These purified recombinant proteins increased the numbers of cells in treated specimens compared with non-treated specimens and control hEGF samples. The collagen-binding activities were also evaluated. Furthermore, CBD-hybridized hEGF induced phosphorylation of the EGF receptor. These results suggested that these fusion proteins could be applicable as small therapeutic agents in wound tissue healing.

Keywords

Collagen-binding domain; fusion protein; human epidermal growth factor; wound healing agent;

Citations & Related Records

Reference

1	Carpenter G, Cohen S. 1976. ¹²⁵I-labeled human epidermal growth factor. Binding internalization, and degradation in human fibroblast. J. Cell Biol. 71: 159-171. DOI ScienceOn
2	Carpenter G, Cohen S. 1979. Epidermal growth factor. Ann. Rev. Biochem. 48: 193-216. DOI ScienceOn
3	Chen X, Cen P, Chen J. 2005. Enhanced production of human epidermal growth factor by a recombinant Escherichia coli integrated with in situ exchange of acetic acid by macroporous ion-exchange resin. J. Biosci. Bioeng. 5: 579-581. DOI ScienceOn
4	Chung KH, Park SH, Kim MK, Park HD, Son TI. 2006. Stabilization of epidermal growth factor on thermal and proteolytic degradation by conjugation with low molecular weight chitosan. J. Appl. Polym. Sci. 102: 5072-5082. DOI ScienceOn
5	Dagmar P, Anspach FB. 2000. Endotoxin removal from protein solution. J. Biotechnol. 76: 97-119. DOI ScienceOn
6	Elloumi I, Kobayashi R, Funabashi H, Mie M, Kobatake E. 2006. Construction of epidermal growth factor fusion protein with cell adhesive activity. Biomaterials 27: 3451-3458. DOI ScienceOn
7	Elloumi HI, Nakamura M, Mie M, Kobatake E. 2009. Construction of multifunctional proteins for tissue engineering: epidermal growth factor with collagen binding and cell adhesive activities. J. Biotechnol. 139: 19-25. DOI ScienceOn
8	Hardwicke J, Schmaljohann D, Boyce D, Thomas D. 2008. Epidermal growth factor therapy and wound healing – past, present and future perspective. Surgeon 6: 172-177. DOI ScienceOn
9	Hayashi M, Tomita M, Yoshizato K. 2001. Production of EGF-collagen chimeric protein which shows the mitogenic activity. Biochem. Biophys. Acta 1528: 187-195. DOI ScienceOn
10	Kim DG, Min MK, Ahn SC, Kim JK, Kong IS. 2009. Expression of a fusion protein containing human epidermal growth factor and the collagen-binding domain of Vibrio mimicus. Biotechnol. Lett. 31: 259-264. DOI ScienceOn
11	Ishikawa T, Terai H, Kitajima T. 2001. Production of a biologically active epidermal growth factor fusion protein with high collagen affinity. J. Biochem. 129: 627-633. DOI ScienceOn
12	Liu YL, Huang LM, Lin WP, Tsai CC, Lin TS, Hu YH, et al. 2006. Secretion of biologically active human epidermal growth factor from Escherichia coli using Yersinia pestis Caf1 signal peptide. J. Microbiol. Immunol. Infect. 39: 366-371.
13	Ishikawa T, Terai H, Yamamoto T, Harada K, Kitajima T. 2003. Delivery of a growth factor fusion protein having collagen-binding activity to wound tissues. Artif. Organs 27: 147-154. DOI ScienceOn
14	Kitajima T, Makoto S, Hirokazu H, Takeshi O, Yoshihiro I. 2009. A chimeric epidermal growth factor with fibrin affinity promotes repair of injured keratinocyte sheets. Acta Biomater. 5: 2623-2632. DOI ScienceOn
15	Lee JH, Ahn SH, Lee EM, Jeong SH, Kim YO, Lee SJ, Kong IS. 2005. The FAXWXXT motif in the carboxyl terminus of Vibrio mimicus metalloprotease is involved in binding to collagen. FEBS Lett. 579: 2507-2513. DOI ScienceOn
16	Nakagawa S, Yoshida S, Hirao Y, Kasuga S, Fuwa T. 1985. Biological effects of biosynthetic human EGF on the growth of mammalian cell in vitro. Differentiation 29: 284-288. DOI
17	Nimni ME. 1997. Polypeptide growth factors: targeted delivery systems. Biomaterials 18: 1201-1225. DOI ScienceOn
18	Nishi N, Matsushita O, Yuube K, Miyanaka H, Okabe A, Wada F. 1998. Collagen-binding growth factors: production and characterization of functional fusion protein having a collagen-binding domain. Proc. Natl. Acad. Sci. USA 95: 7018-7023. DOI
19	Rustad KC, Sorkin M, Levi B, Longaker MT, Gurtner GC. 2010. Strategies for organ level tissue engineering. Organogenesis 6: 151-157. DOI ScienceOn
20	Sahasrabuddhe AA, Ahmed N, Krishnasastry MV. 2006. Stress-induced phosphorylation of caveolin-1 and p38, and down-regulation of EGFr and ERK by the dietary lectin jacalin in two human carcinoma cell lines. Cell Stress Chaperones 11: 135-147. DOI
21	Schlessinger J, Schreiber AB, Levi A, Lax I, Libermann T, Yarden Y. 1983. Regulation of cell proliferation by epidermal growth factor. CRC Crit. Rev. Biochem. 14: 93-111. DOI
22	Yang Y, Zhao Y, Chen B, Han Q, Sun W, Xio Z, Dai J. 2009. Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds. Tissue Eng. A 15: 3589-3596. DOI
23	Yin J, Xu K, Zhang J, Kumar A, Yu FX. 2007. Wound-induced ATP release and EGF receptor activation in epidermal cells. J. Cell Sci. 120: 815-825. DOI ScienceOn
24	Imanishi J, Kamiyama K, Iguchi I, Kita M, Sotozono C, Kinoshita S. 2000. Growth factors: importance in wound healing and maintenance of transparence of the cornea. Prog. Retin. Eye Res. 19: 113-129. DOI ScienceOn
25	Egawa EY, Kato K, Hiraoka M, Nakaji-Hirabayashi T, Iwata H. 2011. Enhanced proliferation of neural stem cells in a collagen hydrogel incorporating engineered epidermal growth factor. Biomaterials 32: 4737-4743. DOI ScienceOn

Reference

3	(2015) Microbiology and biotechnology letters Evaluation of the Wound-healing Activity of Rice Cell Extracts in Vitro / 44 (3) , 285
2	(2015) Tissue engineering. Part B, Reviews Design and Use of Chimeric Proteins Containing a Collagen-Binding Domain for Wound Healing and Bone Regeneration / 23 (2) , 163
1	(2015) Journal of applied microbiology C‐terminal domains of bacterial proteases: structure, function and the biotechnological applications / 122 (1) , 12
8	(2015) Cell transplantation Peptide-Modified Chitosan Hydrogels Accelerate Skin Wound Healing by Promoting Fibroblast Proliferation, Migration, and Secretion / 26 (8) , 1331
2	(2018) Neural regeneration research : NRR Modified insulin-like growth factor 1 containing collagen-binding domain for nerve regeneration / 13 (2) , 298
None	(2015) Scientific reports Angiogenic Properties of ‘Leukocyte- and Platelet-Rich Fibrin’ / 8 (None) , 14632
14	(2019) Applied and environmental microbiology Mechanistic Insight into the Binding and Swelling Functions of Prepeptidase C-Terminal (PPC) Domains from Various Bacterial Proteases / 85 (14) , e00611-19
None	(2015) Frontiers in pharmacology Targeted Delivery of <SUP>111</SUP> In Into the Nuclei of EGFR Overexpressing Cells <I>via</I> Modular Nanotransporters With Anti-EGFR Affibody / 11 (None) , 176
2	(2015) Journal of drug targeting Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents / 28 (2) , 129